Pharmaceutical From Standard to Specialist Capsule Formats Hard gelatin, HPMC, inhalation and vaginal formats engineered for every therapeutic need. View all →
Nutraceutical Consumer-Ready Nutraceutical Formats Capsules and branded ingredients built for supplement manufacturers who demand differentiation. Explore range →
Advanced Formulation Beyond the Standard Capsule Liquid-fill, dual-release and multiparticulate technologies for complex formulations. Explore technologies →
Innovation Always One Step Ahead in Drug Delivery Latest equipment, services and technology partnerships to keep production at the cutting edge. Discover what's new →
CDMO Partnership
From concept to market-ready product — your end-to-end nutraceutical development partner.
Pharmaceutical CDMO
Our Innovaform Accelerator and Tampa facility combine formulation science with scalable manufacturing.
Our Story
A global leader in capsule technologies, committed to advancing pharmaceutical and nutraceutical science.
Basel (CH), 31 August 2018 – Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is launching the Capsugel® Colorista™ product, a high-quality capsule based on an “all-colorants” formulation. This new capsule further expands the Lonza Capsugel® R&D offering.
Colorista™ capsules contain a broad selection of colorants suitable for use in major markets, allowing pharmaceutical customers to have access to a wide array of colors, and are available in both Vcaps® Plus (HPMC) and Coni-Snap® gelatin.
“A common issue faced by drug product developers is that the color composition choice for the commercial drug product is often made after initial stability studies. If new colors are introduced, it may require additional studies, which can result in costly delays," said Emmanuelle Saugues, Color Lab EMEA Supervisor for Lonza. "To address this problem, we have developed Colorista™ capsules at the Capsugel® Color Lab.”
Colorista™ capsules offer more than 150 color options in Coni-Snap® gelatin capsules and more than 50 color options in Vcaps® Plus capsules and are available in different sizes to enable the encapsulation of a wide range of doses and formulations.
Niki Kolokotronis, Sales Director Americas for Capsule Delivery Solutions, explained: “Colorista™ capsules meet the demand of our pharmaceutical customers who look for solutions that cut down on development time while giving them flexibility to progress with technical development before the final commercial color decision is taken.”
Like all other products in the Capsugel® portfolio, Colorista™ capsules rely on Color Lab services, as well as regulatory and compliance support, to help Lonza's customers in the formulation, design and manufacturing of high-quality oral delivery solutions.
The addition of Colorista™ capsules broaden the already comprehensive pre-clinical and clinical portfolio of Capsugel® empty capsules, providing solutions for the full drug product development process.
More information about Capsugel Colorista™ capsules is available here.